Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs PlushCare

Gala and PlushCare both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
PlushCare logo

PlushCare

6.4
★★★☆☆3.2/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit PlushCare →

If you are choosing between Gala and PlushCare, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 6.4.

Gala vs PlushCare price

Gala and PlushCare start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide is cheaper at PlushCare ($149 a month vs $179 a month); tirzepatide is cheaper at Gala ($149 a month vs $399 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Gala prices compounded injections and brand-name pens, while PlushCare prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.

Where each one treats patients

Gala lists 50 states, and PlushCare lists 50 states.

They overlap in 50 states.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

PlushCare

StartingCompounded
$149/mo
semaglutide

Range up to $299/mo

StartingCompounded
$399/mo
tirzepatide

Range up to $599/mo

What each price covers

Gala's price also covers the clinician visit, the medication itself and shipping, which PlushCare does not claim.

Gala is silent on lab work and coaching.

PlushCare is silent on shipping and coaching.

That matters most for the drug: unless PlushCare confirms otherwise, budget for medication on top of its listed price.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

PlushCare

Covered by the monthly price

Medication

Charged on top

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Charged on top

Coaching

Not stated

Where each one scores higher

Overall, Gala scores 8.7 and PlushCare 6.4 out of 10.

Gala is stronger on value (8.7 vs 3.0), user experience (8.0 vs 7.0) and support (7.0 vs 0.0).

Effectiveness, trust & safety and accessibility are within half a point.

How we score

Gala

8.7/10

Overall

PlushCare

6.4/10

Value25%

8.7A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
7.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
0.0

FDA warning letters

Neither Gala nor PlushCare has an FDA warning letter on record with us.

Features & Coverage

FeatureGalaPlushCare
Starting Price$149/mo$149/mo
Features7 features✓8 features
States Available5050
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About PlushCare

PlushCare is an established virtual primary-care telehealth platform and a subsidiary of Transcarent, Inc., a Delaware corporation that also owns Accolade, 2nd.MD, and 98point6 by Transcarent. Virtual visits with US board-certified physicians cost $30 per appointment insured and $129 self-pay. GLP-1 prescribing is a clinician-discretionary option within the broader primary-care relationship.

Read our full PlushCare review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

PlushCare

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • Serves all 50 states
  • We found no FDA warning letters issued to PlushCare
  • A live video visit with a clinician is required before a prescription, which is slower than a form and is the more careful intake
  • Baseline bloodwork is required before a prescription

Watch-outs

  • Not included in the monthly price: medication, clinician visits, lab work
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 6.4, above all for moving between compounded and brand without changing seller. PlushCare fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose PlushCare if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

Gala vs PlushCare: FAQ

Neither on the entry price: Gala and PlushCare both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Both list 50 states and share 50.
Only Gala includes the clinician visit, the medication itself and shipping.
Gala has none. PlushCare has none.
Gala pays us a commission on sign-ups through our links; PlushCare does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.